Differential Effects of Denileukin Diftitox IL-2 Immunotoxin on NK and Regulatory T Cells in Nonhuman Primates

Differential Effects of Denileukin Diftitox IL-2 Immunotoxin on NK and Regulatory T Cells in Nonhuman Primates
复制标题

DOI:
10.4049/jimmunol.1200656
复制
发表时间:
2012-06-15
影响因子:
4.4
通讯作者:
Kawai, Tatsuo
Kawai, Tatsuo
中科院分区:
医学2区
文献类型:
--
作者:
Yamada, Yohei;Aoyama, Akihiro;Kawai, Tatsuo

文献摘要

被引文献

相似文献

Denileukin diftitox (DD)是一种包含IL-2和白喉毒素的融合蛋白,最初期望通过选择性地消除显示高亲和力IL-2R (α - β - γ三聚体)的调节性T细胞(Tregs)来增强抗肿瘤免疫。虽然DD在灵长类动物中被证明会消耗一些Tregs,但它对NK细胞(CD16(+)CD8(+)NKG2A(+)CD3(-))的影响仍然未知,NK细胞组成性地表达中等亲和力的IL-2R (β - γ二聚体),并在抗肿瘤免疫中发挥关键作用。为了解决这个问题,食蟹猴被静脉注射了两种剂量的DD(8或18 μ g/kg)。这种治疗导致可检测到的外周血静息treg (CD4(+)CD45RA(+)Foxp3(+))的快速但短期的降低和激活treg (CD4(+)CD45RA(-)Foxp3(高))数量的短暂增加,随后它们的部分消耗(50-60%)。相反,所有NK细胞在给药后立即和持久地消失。与Tregs相比,这种差异不是由于NK细胞对DD的结合或内化程度更高。DD与IL-15(与IL-2R β - γ结合)共同给药,在体外和体内消除了DD诱导的NK细胞缺失,而不影响Treg的消除。综上所述,这些结果表明,DD对NK细胞具有强大的细胞毒作用,这种现象可能会损害其抗肿瘤特性。然而,IL-15与DD联合使用可以通过选择性地保护潜在的溶瘤性NK细胞来缓解这一问题,同时允许癌症患者消耗免疫抑制Tregs。免疫学杂志,2012,18(8):6063-6070。
Denileukin diftitox (DD), a fusion protein comprising IL-2 and diphtheria toxin, was initially expected to enhance antitumor immunity by selectively eliminating regulatory T cells (Tregs) displaying the high-affinity IL-2R (alpha-beta-gamma trimers). Although DD was shown to deplete some Tregs in primates, its effects on NK cells (CD16(+)CD8(+)NKG2A(+)CD3(-)), which constitutively express the intermediate-affinity IL-2R (beta-gamma dimers) and play a critical role in antitumor immunity, are still unknown. To address this question, cynomolgus monkeys were injected i.v. with two doses of DD (8 or 18 mu g/kg). This treatment resulted in a rapid, but short-term, reduction in detectable peripheral blood resting Tregs (CD4(+)CD45RA(+)Foxp3(+)) and a transient increase in the number of activated Tregs (CD4(+)CD45RA(-)Foxp3(high)), followed by their partial depletion (50-60%). In contrast, all NK cells were deleted immediately and durably after DD administration. This difference was not due to a higher binding or internalization of DD by NK cells compared with Tregs. Coadministration of DD with IL-15, which binds to IL-2R beta-gamma, abrogated DD-induced NK cell deletion in vitro and in vivo, whereas it did not affect Treg elimination. Taken together, these results show that DD exerts a potent cytotoxic effect on NK cells, a phenomenon that might impair its antitumoral properties. However, coadministration of IL-15 with DD could alleviate this problem by selectively protecting potentially oncolytic NK cells, while allowing the depletion of immunosuppressive Tregs in cancer patients. The Journal of Immunology, 2012, 188: 6063-6070.